Gefitinib is used to treat lung cancer. Acting in a similar manner to erlotinib gefitinib selectively targets the mutant proteins in malignant cells. It is marketed by AstraZeneca under the trade name Iressa. Reference standards of Gefitinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Gefitinib for system suitability (Y0001809) [catalogue_number] => PA EPY0001809 [category_ids] => ,150, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => gefitinib-for-system-suitability-y0001809-paepy0001809 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA EPY0001809
CAS :
Molecular Formula : NA
Molecular Weight : NA
stdClass Object ( [pname] => Gefitinib (Y0001813) [catalogue_number] => PA EPY0001813 [category_ids] => ,150, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => gefitinib-y0001813-paepy0001813 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA EPY0001813
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
